MEDOCHEMIE was
established in 1976 in Cyprus
by Dr. Andreas Pittas

The journey has seen our active expansion into promising markets across the world – from our base in Europe, to the Middle East & Africa and through to the Far East . Outside our 19 core offices, we developed a network of trusted agents and partners allowing us to operate in 122 countries.

Today, Medochemie Ltd has fifteen manufacturing plants and facilities. Nine are in Cyprus, one in the Netherlands, and five in Vietnam. We have acquired and maintain 5,145 marketing authorisation licences for 630 different pharmaceutical products, classified in over 10 therapeutic categories. We operate in accordance with the strictest quality standards and in full compliance with European guidelines.

The driving force behind Medochemie is our 2000 multinational, talented, quality-focused employees, who work in our manufacturing plants and offices worldwide.

Medochemie is a founding member of the Medicines for Europe (former EGA).